Moderna develops hybrid vaccine against both coronavirus and influenza

 

Moderna is developing a hybrid booster vaccine against both Covid-19 and the flu.

Pharmaceutical giant Moderna has announced that it is developing a booster vaccine. or a hybrid shot booster that can prevent both Covid-19 and influenza in one needle

The vaccine Moderna is developing, called mRNA-1073, is a combination of Moderna's Covid-19 vaccine with an in-development influenza vaccine.

Stephen Bancel, CEO of Moderna, said: “Today we announce the start of a new respiratory vaccine program with the development of a single-dose vaccine in combination with a booster vaccine against Covid- 19 and an anti-flu booster.”

Bongcel continued: “We are making progress in recruiting patients to our Rare Disease Program. And we have full candidates for personalized cancer vaccines. We believe this is just the beginning of a new era of data-driven medicine.”

• The Bangkok Metropolitan Administration began vaccinating Pfizer's first dose of high-risk children on September 21.
• "Doctor Theera" warns that "the sky is starting to light up" will be a warning signal that the storm is coming.

In addition, Moderna announced that it is developing a vaccine for children, mRNA-1365, that will deliver a vaccine against RSV that causes both upper and lower respiratory tract infections. and vaccine against acute respiratory infections

The announcement of the good news sent Moderna shares jumping more than 5%.

According to the US Centers for Disease Control and Prevention (CDC), more than 147 million doses of Moderna's Covid-19 vaccine have been vaccinated in the United States.

REUTERS/Mike Segar/File Photo